ResearcherInsermActive in the last 2 years

Jean Pinson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4165-4233; OpenAlex author ID A5026120627. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 1 paper

Papers 1

New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study of the PANACHE01-PRODIGE48 Trial. Co-author DOI 10.1097/sla.0000000000006468 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Frédéric Di Fiore · 1 shared paper, 2024 · strength 0.22
- Paper New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study… DOI 10.1097/sla.0000000000006468 ↗
Déwi Vernerey · 1 shared paper, 2024 · strength 0.22
- Paper New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study… DOI 10.1097/sla.0000000000006468 ↗
Lilian Schwarz · 1 shared paper, 2024 · strength 0.22
- Paper New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study… DOI 10.1097/sla.0000000000006468 ↗
António Sá Cunha · 1 shared paper, 2024 · strength 0.22
- Paper New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study… DOI 10.1097/sla.0000000000006468 ↗
Jean‐Baptiste Bachet · 1 shared paper, 2024 · strength 0.22
- Paper New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study… DOI 10.1097/sla.0000000000006468 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.